Inclusion Criteria : 
  -  Patients with ( suspicion of ) primary or recurrent EOC with an indication for surgery , chemotherapy and / or immunotherapy. 
  -  Age â‰¥ 18 years. 
  -  WHO performance status 0 - 2. 
  -  Accessible for treatment and follow - up. 
  -  Written informed consent. 
Exclusion Criteria : 
  -  Other active malignancy in past 5 years prior to entry into the study , except for treated non - melanoma skin cancer. 
  -  Any known severe infection like HIV , hepatitis A , B and C. 
  -  Receiving immune suppressive treatment. 
  -  Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent.